DE69426035D1 - Radiomarkierte glukane - Google Patents

Radiomarkierte glukane

Info

Publication number
DE69426035D1
DE69426035D1 DE69426035T DE69426035T DE69426035D1 DE 69426035 D1 DE69426035 D1 DE 69426035D1 DE 69426035 T DE69426035 T DE 69426035T DE 69426035 T DE69426035 T DE 69426035T DE 69426035 D1 DE69426035 D1 DE 69426035D1
Authority
DE
Germany
Prior art keywords
agents
methods
specifically
glucane
marked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69426035T
Other languages
English (en)
Other versions
DE69426035T2 (de
Inventor
T Dean
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CIS Bio International SA
Original Assignee
Diatide Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diatide Inc filed Critical Diatide Inc
Application granted granted Critical
Publication of DE69426035D1 publication Critical patent/DE69426035D1/de
Publication of DE69426035T2 publication Critical patent/DE69426035T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0493—Steroids, e.g. cholesterol, testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE69426035T 1993-07-28 1994-07-28 Radiomarkierte glukane Expired - Fee Related DE69426035T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9820693A 1993-07-28 1993-07-28
PCT/US1994/008501 WO1995003836A2 (en) 1993-07-28 1994-07-28 Radiolabelled glucans

Publications (2)

Publication Number Publication Date
DE69426035D1 true DE69426035D1 (de) 2000-11-02
DE69426035T2 DE69426035T2 (de) 2001-05-17

Family

ID=22267997

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69426035T Expired - Fee Related DE69426035T2 (de) 1993-07-28 1994-07-28 Radiomarkierte glukane

Country Status (12)

Country Link
US (6) US5814299A (de)
EP (1) EP0788377B1 (de)
JP (2) JP3320734B2 (de)
AT (1) ATE196609T1 (de)
AU (1) AU698176B2 (de)
CA (1) CA2167807C (de)
DE (1) DE69426035T2 (de)
DK (1) DK0788377T3 (de)
ES (1) ES2151933T3 (de)
GR (1) GR3034918T3 (de)
WO (1) WO1995003836A2 (de)
ZA (1) ZA945587B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436365B2 (en) * 1997-09-23 2002-08-20 Schering Aktiengesellschaft Process for therapeutic treatment of proliferative diseases
US6245316B1 (en) 1997-10-08 2001-06-12 David Platt Enhancement of delivery of radioimaging and radioprotective agents
WO2000033891A1 (en) * 1998-12-04 2000-06-15 Medivas, Llc Methods for detection of vulnerable plaques using a detectable lipid-avid agent
US6409987B1 (en) 1999-04-07 2002-06-25 Intimax Corporation Targeted agents useful for diagnostic and therapeutic applications
US7004168B2 (en) 2001-09-07 2006-02-28 Respironics, Inc. Face mask for gas monitoring during supplemental oxygen delivery
CN104511030A (zh) * 2013-09-29 2015-04-15 复旦大学 基于葡聚糖的双模态纳米影像药物-Dex-Rho-99mTc
GB201402132D0 (en) * 2014-02-07 2014-03-26 South African Nuclear Energy A method of producing ethylenedicysteine deoxyglucosamine (ECDG) or a salt thereof and its application in a kit

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002730A (en) * 1975-01-13 1977-01-11 The Procter & Gamble Company Radionuclide carriers
US4385046A (en) * 1980-12-15 1983-05-24 Minnesota Mining And Manufacturing Company Diagnostic radio-labeled polysaccharide derivatives
US4431626A (en) * 1981-05-27 1984-02-14 The Regents Of The University Of California Tc-99m Labeled carrier for imaging
US4439414A (en) * 1982-01-26 1984-03-27 The United States Of America As Represented By The United States Department Of Energy 1-11 C-D-Glucose and related compounds
SE456911B (sv) * 1983-12-19 1988-11-14 Olle Larm Vattenloeslig, aminerad beta-1,3-bunden d-glukan och makrofagstimulerande komposition innehaallande densamma
FR2588575B1 (fr) * 1985-10-16 1988-02-26 Brochier Sa Tissu a base de fibres de verre et de carbone et articles comprenant un tel tissu
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
US4952393A (en) * 1987-04-02 1990-08-28 The General Hospital Corporation Organ infarct imaging with technetium labelled glucarate
GB8801646D0 (en) * 1988-01-26 1988-02-24 Nycomed As Chemical compounds
US4946668A (en) * 1988-10-07 1990-08-07 Centocor, Inc. Tumor imaging with technetium labelled glucarate
US5057503A (en) * 1989-01-23 1991-10-15 The Brigham And Women's Hospital Derivativized polysaccharides with biologic activity, method of their isolation, and uses therefor
FR2644059B1 (fr) * 1989-03-08 1994-03-04 Fabre Medicament Pierre Compositions aerosols destinees a l'imagerie, au diagnostic et a la therapie ciblee de foyers inflammatoires et tumoraux
US5032401A (en) * 1989-06-15 1991-07-16 Alpha Beta Technology Glucan drug delivery system and adjuvant
JP2690018B2 (ja) * 1989-07-13 1997-12-10 日本メジフィジックス株式会社 グルコサミン誘導体よりなる放射性診断剤
WO1991003248A2 (en) * 1989-09-08 1991-03-21 Alpha Beta Technology, Inc. Method for immune system activation
JPH05503952A (ja) * 1989-09-08 1993-06-24 アルファ　ベータ　テクノロジー，インコーポレイティッド 可溶性グルカン類の製造方法
US5368840A (en) * 1990-04-10 1994-11-29 Imarx Pharmaceutical Corp. Natural polymers as contrast media for magnetic resonance imaging
US5211937A (en) * 1990-07-30 1993-05-18 Glycomed Incorporated Method of determining a site of inflammation utilizing elam-1 ligands
US5561220A (en) * 1991-02-08 1996-10-01 Diatech, Inc. Technetium-99m labeled peptides for imaging inflammation
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
DE69230525T2 (de) * 1991-02-08 2000-06-21 Diatide, Inc. Technetium-99m markierte Polypeptide zur Bildformung
JP2894879B2 (ja) * 1991-10-04 1999-05-24 日本メジフィジックス株式会社 診断用造影剤
ES2194846T3 (es) * 1992-03-13 2003-12-01 Diatide Inc Peptidos marcados con tecnecio-99m para obtencion de imagenes de inflamacion.
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
JP2941057B2 (ja) * 1992-05-21 1999-08-25 ダイアテク，インコーポレイテッド 血栓造影用のテクネチウム‐９９ｍ標識ペプチド
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
WO1994002068A1 (en) * 1992-07-21 1994-02-03 The General Hospital Corporation System of drug delivery to the lymphatic tissues

Also Published As

Publication number Publication date
US5851509A (en) 1998-12-22
GR3034918T3 (en) 2001-02-28
US5843403A (en) 1998-12-01
EP0788377B1 (de) 2000-09-27
CA2167807C (en) 2001-05-01
DE69426035T2 (de) 2001-05-17
WO1995003836B1 (en) 2001-04-05
JPH09500172A (ja) 1997-01-07
WO1995003836A2 (en) 1995-02-09
US5814299A (en) 1998-09-29
ATE196609T1 (de) 2000-10-15
US5770179A (en) 1998-06-23
ZA945587B (en) 1995-05-15
WO1995003836A3 (en) 1995-04-06
EP0788377A2 (de) 1997-08-13
JP2001354594A (ja) 2001-12-25
US5879660A (en) 1999-03-09
AU7827494A (en) 1995-02-28
CA2167807A1 (en) 1995-02-09
US5820846A (en) 1998-10-13
DK0788377T3 (da) 2000-12-27
ES2151933T3 (es) 2001-01-16
JP3320734B2 (ja) 2002-09-03
AU698176B2 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
ES2194846T3 (es) Peptidos marcados con tecnecio-99m para obtencion de imagenes de inflamacion.
DK0684843T3 (da) Technetium-99m-mærkede peptider til diagnostisk billeddannelse af inflammation
DK0759786T3 (da) Somatostatinbindende peptidmetal-chelatkonjugater
DK0644778T3 (da) Technetium-99-mærkede peptider til imagografi
DK0641222T3 (da) Peptider mærket med technetium-99m til trombeafbildning
DK0702570T3 (da) Technetium-99m-mærkede peptider til afbildning af inflammation
DE69531613D1 (de) Einführung einer thiol-gruppe in proteine für die radioimmundetektion und radioimmuntherapie auf der basis von radionukliden
AU7366687A (en) Coupling agents for radiolabeling proteins
MX9709126A (es) Reactivos estables para la preparacion de radiofarmacos.
PT762901E (pt) Peptidos marcados com tecnecio-99m para imagiologia.
ES2194908T3 (es) Agentes de produccion de imagenes marcados con tecnecio-99m.
DE69426035D1 (de) Radiomarkierte glukane
CA2190108A1 (en) Somatostatin binding peptide-metal chelate conjugates

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: CIS BIO INTERNATIONAL, GIF-SUR-YVETTE, FR

8328 Change in the person/name/address of the agent

Representative=s name: DF-MP, 80333 MUENCHEN

8339 Ceased/non-payment of the annual fee